✦ LIBER ✦

183: High-dose thiotepa, busulfan, and cyclophosphamide for allogeneic stem cell transplantion in risk pedaitric patients with high-risk leukemias

✍ Scribed by L.L. Worth; S.E. Koontz; D. Petropoulos; H.T. Tran; M.S. Choroszy; K. Chan

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II Trial of Busulfan-Based Tandem

✍ Chen, Yi-Bin; Li, Shuli; Del Rio, Candice; Driscoll, Jessica; Sadrzadeh, Hossein 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 220 KB

Phase I trial and pharmacokinetic study

✍ Schwartz, J E; Srivastava, S; Nelson, R P; Robertson, M J; Abonour, R; Secrest, 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 359 KB

High-dose busulfan, cyclophosphamide, an

✍ Farag, S S; Bolwell, B J; Elder, P J; Kalaycio, M; Lin, T; Pohlman, B; Penza, S; 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 191 KB

High-dose thiotepa, etoposide and carbop

✍ Franca Falzetti,Mauro Di Ianni,Stelvio Ballanti… 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 235 KB

Allogeneic Hematopoietic Stem Cell Trans

✍ Bakr, Mohammad; Rasheed, Walid; Mohamed, Said Y.; Al-Mohareb, Fahad; Chaudhri, N 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 264 KB

Thiotepa (TT), Busulfan (Bu), And Clofar

✍ L.L. Worth; B.S. Andersson; R. Kazerooni; D. Petropoulos; S.S. Kelly; D.A. Lee; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 82 KB